US2003077795A1PendingUtilityA1

Cytochrome P450 monooxygenase and NADPH Cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicals and methods relating thereto

Priority: Mar 10, 1999Filed: Oct 12, 2001Published: Apr 24, 2003
Est. expiryMar 10, 2019(expired)· nominal 20-yr term from priority
C12N 9/0042C07K 14/40C12N 9/0071C12N 9/0077C12P 7/44
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Novel genes have been isolated which encode cytochrome P 450 and NADPH reductase enzymes of the co-hydroxylase complex of C. tropicalis 20336. Vectors including these genes, transfected host cells and transformed host cells are provided. Methods of producing of cytochrome P 450 and NADPH reductase enzymes are also provided which involve transforming a host cell with a gene encoding these enzymes and culturing the cells. Methods of increasing the production of a dicarboxylic acid and methods of increasing production of the aforementioned enzymes are also provided which involve increasing in the host cell the number of genes encoding these enzymes. A method for discriminating members of a gene family by quantifying the expression of genes is also provided.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . Isolated nucleic acid encoding a CYP52A2B protein having the amino acid sequence set forth in SEQ ID NO: 97.  
     
     
         2 . Isolated nucleic acid comprising a coding region defined by nucleotides 1072-2640 as set forth in SEQ ID NO: 87.  
     
     
         3 . Isolated nucleic acid according to  claim 2  comprising the nucleotide sequence as set forth in SEQ ID NO: 87.  
     
     
         4 . A vector comprising a nucleotide sequence encoding CYP52A2B protein including an amino acid sequence as set forth in SEQ ID NO: 97.  
     
     
         5 . A vector according to  claim 4  wherein the nucleotide sequence is set forth in nucleotides 1072-2640 of SEQ ID NO: 87.  
     
     
         6 . A vector according to  claim 4  wherein the vector is selected from the group consisting of plasmid, phagemid, phage and cosmid.  
     
     
         7 . A host cell transfected or transformed with the nucleic acid of  claim 1 .  
     
     
         8 . A host cell according to  claim 7  wherein the host cell is a yeast cell.  
     
     
         9 . A host cell according to  claim 8  wherein the yeast cell is a  Candida sp.    
     
     
         10 . A host cell according to  claim 9  wherein the  Candida sp.  is  Candida tropicalis.    
     
     
         11 . A host cell according to  claim 10  wherein the  Candida tropicalis  is  Candida tropicalis  20336.  
     
     
         12 . A host cell according to  claim 11  wherein the  Candida tropicalis  is H5343 ura−.  
     
     
         13 . A method of producing a CYP52A2B protein including an amino acid sequence as set forth in SEQ ID NO: 97 comprising: 
 a) transforming a suitable host cell with a DNA sequence that encodes the protein having the amino acid sequence as set forth in SEQ ID NO: 97; and    b) culturing the cell under conditions and in media favoring the expression of the protein.    
     
     
         14 . The method according to  claim 13  wherein the step of culturing the cell comprises adding an organic substrate to the media containing the cell.  
     
     
         15 . A method for increasing production of a dicarboxylic acid comprising: 
 a) providing a host cell having a naturally occurring number of CYP52A2B genes;    b) increasing, in the host cell, the number of CYP52A2B genes which encode a CYP52A2B protein having the amino acid sequence as set forth in SEQ ID NO: 97;    c) culturing the host cell in media containing an organic substrate which upregulates the CYP52A2B gene, to effect increased production of dicarboxylic acid.    
     
     
         16 . A method for increasing the production of a CYP52A2B protein having an amino acid sequence as set forth in SEQ ID NO: 97 comprising: 
 a) transforming a host cell having a naturally occurring amount of CYP52A2B protein to increase the copy number of CYP52A2B genes that encode the CYP52A2B protein having the amino acid sequence as set forth in SEQ ID NO: 97; and    b) culturing the cell and thereby increasing expression of the protein as compared to an untransformed host cell.

Join the waitlist — get patent alerts

Track US2003077795A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.